Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 26, 2005
Anti-mullerian hormone as a marker of ovarian reserveKelton P Tremellen, Michele Kolo, Alan Gilmore, et al.
Computational and Structural Biotechnology Journal|October 17, 2022
Particle swarm optimization artificial intelligence technique for gene signature discovery in transcriptomic cohortsRoss G Murphy, Alan Gilmore, Seedevi Senevirathne, et al.
Molecular Biology and Evolution|August 20, 2019
NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free MethodsAideen C Roddy, Anna Jurek-Loughrey, Jose Souza, et al.
Computational and Structural Biotechnology Journal|July 14, 2022
A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancerJames P Beirne, Alan Gilmore, Caitríona E McInerney, et al.
NAR Genomics and Bioinformatics|April 30, 2021
Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancerMatthew Alderdice, Stephanie G Craig, Matthew P Humphries, et al.
JCO Precision Oncology|October 17, 2018
Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease ProgressionAlexey Stupnikov, Paul G O'Reilly, Caitriona E McInerney, et al.
Oncotarget|March 24, 2018
Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.
Gynecologic Oncology|September 9, 2019
Defining the molecular evolution of extrauterine high grade serous carcinomaJames P Beirne, Darragh G McArt, Aideen Roddy, et al.
Pageof 1